Lactobacillus delbrueckii bulgaricus.

The two organisms feed each other during fermentation: the bulgaricus strain has strong proteolytic activity and liberates peptides and amino acids that S. thermophilus needs, while S. thermophilus produces formate and carbon dioxide that stimulate the bulgaricus strain. Each grows faster together than alone. This protocooperation is the reason yoghurt exists in the form it does.

The bacterial cell acts as a delivery vehicle for its own beta-galactosidase, which is the same reaction supplemental lactase performs. The effect of live yoghurt culture on lactose digestion is well enough characterised to have been accepted as a health relationship by European regulators. Supplemental lactase does the same job through a different route and the two are not in conflict.

L. acidophilus is more bile tolerant and more likely to transit the gut alive, while the bulgaricus strain is a dairy fermentation organism that generally does not colonise. Combining them in a product gives both a fermentation workhorse and a strain with better survival characteristics. This is standard formulation logic in the yoghurt and supplement industries.

Standard yoghurt starters ferment the milk but are poorly adapted to bile and low pH in the gut, which is why manufacturers add bifidobacteria for the probiotic positioning. The two roles are different: one makes the yoghurt, the other is meant to reach the colon. Keeping that distinction visible on a label is more honest than counting all CFU together.

Inulin passes the small intestine unchanged and becomes substrate for colonic fermentation, generating short-chain fatty acids. Whether it specifically favours a delivered dairy starter strain over the resident microbiota is much less established than the general synbiotic rationale suggests. Read the pairing as a reasonable formulation logic rather than a demonstrated targeted effect.

GOS is made industrially using the same class of enzyme the organism carries, and it is a well-characterised substrate for lactic acid bacteria and bifidobacteria in the colon. The pairing of a galacto-oligosaccharide with a lactose-fermenting organism has a coherent substrate logic. Human outcome data for this specific pairing is thin.

Calcium must be soluble to be absorbed, and solubility falls as intestinal pH rises. The acidification from lactic acid fermentation works against that. The effect is a property of the fermented food matrix rather than of the isolated organism in a capsule.

Riboflavin biosynthesis capacity varies substantially between strains within this species, so it is a strain property and not a species property. Selected overproducing strains raise the riboflavin content of the fermented product measurably. A generic culture cannot be assumed to do this.

In mixed yoghurt culture the net folate content of the product depends on the balance between the producing and the consuming organism. This is why folate levels differ between yoghurts made with different strain combinations. The direction is strain specific and should not be stated as a property of the species.

Milk is the B12 source, not the bacteria, and lactic acid bacteria vary in how much they take up during growth. Reported B12 losses across fermentation differ by strain and by process. The practical point is that a fermented dairy product is not automatically equivalent to the milk it came from on this nutrient.

The cell envelope proteinase of this species is what breaks down milk protein during fermentation, generating a peptide pool chemically distinct from unfermented milk protein. Bioactivity of some of those peptides has been shown in vitro. Whether the same happens meaningfully in a gut with a capsule product rather than a long fermentation is a different question and is not established.

The yeast is not susceptible to antibacterials, so a combination keeps a live organism present in situations where the bacterial component would be wiped out. The two act by different routes and are not competing for the same niche. This is a coverage argument rather than a demonstrated interaction.

Phytate binds zinc and iron tightly, and fermentation both lowers pH toward the optimum for endogenous phytase and can contribute microbial phytase. The effect is well documented in fermented cereal foods. In a dairy matrix, where phytate is not present to begin with, the relevance is much lower.

Both approaches supply hydrolytic activity into the upper gut, one from a living cell and one as a purified protein. The bacterial route delivers its enzyme protected inside the cell, which changes the survival profile through the stomach. Neither displaces the other and the combination is common in commercial blends.